A multicenter, double-blind, placebo-controlled phase II study of apreipitant for prevention of chemotherapy-induced nausea and vomiting (CINV) following moderately emetogenic chemotherapy (MEC) in women younger than 70 years without alcohol drinking habit
Phase 2
- Conditions
- Female cancer patients younger than 70 years without alcohol drinking habit
- Registration Number
- JPRN-UMIN000004998
- Lead Sponsor
- Hanshin Cancer Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 94
Inclusion Criteria
Not provided
Exclusion Criteria
Any anthracylin and cyclophosphamide (AC) regimens are not permitted.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method